21 CFR § 530.30 - Extralabel drug use in nonfood animals.

---
identifier: "/us/cfr/t21/s530.30"
source: "ecfr"
legal_status: "authoritative_unofficial"
title: "21 CFR § 530.30 - Extralabel drug use in nonfood animals."
title_number: 21
title_name: "Food and Drugs"
section_number: "530.30"
section_name: "Extralabel drug use in nonfood animals."
chapter_name: "FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES"
subchapter_number: "E"
subchapter_name: "ANIMAL DRUGS, FEEDS, AND RELATED PRODUCTS"
part_number: "530"
part_name: "EXTRALABEL DRUG USE IN ANIMALS"
positive_law: false
currency: "2026-04-05"
last_updated: "2026-04-05"
format_version: "1.1.0"
generator: "[email protected]"
authority: "15 U.S.C. 1453, 1454, 1455; 21 U.S.C. 321, 331, 351, 352, 353, 355, 357, 360b, 371, 379e."
regulatory_source: "61 FR 57743, Nov. 7, 1996, unless otherwise noted."
cfr_part: "530"
---


# 530.30 Extralabel drug use in nonfood animals.

(a) Because extralabel use of animal and human drugs in nonfood-producing animals does not ordinarily pose a threat to the public health, extralabel use of animal and human drugs is permitted in nonfood-producing animal practice except when the public health is threatened. In addition, the provisions of § 530.20(a)(1) will apply to the use of an approved animal drug.

(b) If FDA determines that an extralabel drug use in animals not intended for human consumption presents a risk to the public health, the agency may publish in the *Federal Register* a notice prohibiting such use following the procedures in § 530.25. The prohibited extralabel drug use will be codified in § 530.41.